The Inflation Reduction Act, signed by President Biden on Aug. 16th, includes provisions to reduce prescription drug costs for Medicare beneficiaries. Some stakeholders in Arizona believe the provisions do not go far enough to minimize the financial burden of prescription drugs for Arizonans, and some believe that the act will negatively impact drug innovation.   … Read more

According to a new report from the Kaiser Family Foundation (KFF), more than 113,000 Medicare beneficiaries in Colorado could benefit from lower costs to Part D prescription drugs if provisions in the US Senate’s draft legislation are passed.      The Senate Finance Committee recently published legislative text in a forthcoming reconciliation bill that aims … Read more